17th Bleeding and Thrombosing Diseases Conference and Workshop



This conference and workshop will be offered as a hybrid (in-person or virtual) experience due to COVID-19 pandemic spread.

This Mayo Clinic conference will provide reviews and updates about laboratory and clinical aspects of bleeding and thrombosing disorders. Informational presentations will be supplemented with panel discussions and case presentations, followed by time for participant questions.

Learning Objectives:

  • Review hemostasis, including pediatric - kids are not little adults
  • Summarize clinical features and laboratory evaluation of congenital and acquired bleeding disorders including hereditary and acquired hemophilia, hereditary platelet disorders, and von Willebrand disease
  • Evaluate antibody-mediated prothrombotic disorders such as heparin-induced thrombocytopenia, COVID-19 coagulopathy, lupus anticoagulant, and antiphospholipid syndrome
  • Review coagulopathy of trauma and intravascular coagulation and fibrinolysis (ICF/DIC)
  • Explain key features of management of venous thromboembolism (VTE) in the era of DOACs including options for therapy and care for specialized patient populations with VTE (i.e., cancer patients)
  • Discuss features of the direct oral anticoagulant (DOAC) drugs including situations where use is appropriate vs not recommended, and options for DOAC reversal
  • Describe gender related health issues in thrombosis
18 AMA PRA Category 1 Credits™

17.75 ABIM MOC points

Venue: Hilton Rochester Mayo Clinic Area


October 6-8, 2021


Rochester, Minnesota 55904, United States